Cryptococcal Meningitis News and Research

RSS
Cryptococcal meningitis is an infection of the lining of the brain and spinal cord. The fungus that causes this infection is found in soil. The risk is highest when CD4 cell counts are below 100. You can get it by breathing in dust. Symptoms include headache, nausea, fever, fatigue, irritability, sensitivity to light, stiff neck, change in mental state, and hallucinations.
Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Recent estimates reveal burden of serious fungal diseases in 14 different countries

Recent estimates reveal burden of serious fungal diseases in 14 different countries

Could pathogen infection really lead to Alzheimer’s?

Could pathogen infection really lead to Alzheimer’s?

Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

Cryptococcus research: an interview with Associate Professor Kirsten Nielsen

Cryptococcus research: an interview with Associate Professor Kirsten Nielsen

Duke Medicine scientists use transparent fish to show how Cryptococcal meningitis takes over the brain

Duke Medicine scientists use transparent fish to show how Cryptococcal meningitis takes over the brain

Findings reveal a new way to prevent meningitis

Findings reveal a new way to prevent meningitis

Simple low-cost intervention could help reduce HIV-related deaths in Africa

Simple low-cost intervention could help reduce HIV-related deaths in Africa

Leading microbiologist warns of killer fungi’s increasing threat

Leading microbiologist warns of killer fungi’s increasing threat

Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

Drug used for treating breast cancer also kills fungal disease

Drug used for treating breast cancer also kills fungal disease

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Short-course amphotericin is cost-effective for cryptococcal meningitis

Short-course amphotericin is cost-effective for cryptococcal meningitis

University of Nevada researcher to optimize new rapid test for melioidosis

University of Nevada researcher to optimize new rapid test for melioidosis

ZOLOFT holds promise against cryptococcal meningitis

ZOLOFT holds promise against cryptococcal meningitis

Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer

Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer

Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay